🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Barbara Eichhorst

University of Cologne

ORCID: 0000-0001-9990-6918

Also affiliated with Düsseldorf University Hospital, Integrated Oncology (United States), University Hospital Cologne, Heinrich Heine University Düsseldorf

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study”.

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

Journal of Clinical Oncology(2020)10.1200/jco.20.00948
N/A
4.9DataRank · unranked
223 citations

Jenny Wu, Thomas J. Kipps, Barbara Eichhorst, Peter Hillmen, James D’Rozario +23 more

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

Blood(2022)10.1182/blood.2021015014
N/A
3.8DataRank · unranked
153 citations

Thomas J. Kipps, Barbara Eichhorst, James D’Rozario, Carolyn Owen, Sarit Assouline +16 more

International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations

Blood(2025)10.1182/blood.2024028064
N/A
0.425DataRank · unranked
16 citations

Monia Marchetti, Othman Al‐Sawaf, Ohad Benjamini, Alexey V. Danilov, Matthew S. Davids +24 more

Hitting the Therapeutic Bullseye with Targeted Therapy for Patients with Chronic Lymphocytic Leukemia

Blood(2025)10.1182/blood.2025028570
N/A
0.165DataRank · unranked
2 citations

Barbara Eichhorst, Michael Hallek, William G. Wierda

MARCKS affects cell motility and response to BTK inhibitors in CLL

Blood(2021)10.1182/blood.2020009165
N/A
0DataRank · unranked
25 citations

Valeska Berg, Clarissa Dickhut, Clare Sun, Olaf Merkel, Johannes Bloehdorn +22 more